{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:51:21Z","timestamp":1790387481159,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.semcdb.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T22:00:40Z","timestamp":1441317640000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario"],"prefix":"10.1016","volume":"54","author":[{"given":"Fabio","family":"Penna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Argil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2015.09.002_bib0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0255","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0260","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0265","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0270","first-page":"2085","article-title":"Novel in vitro platform to investigate myotube atrophy","volume":"35","author":"Oelkrug","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.devcel.2015.03.001","article-title":"Malignant drosophila tumors interrupt insulin signaling to induce cachexia-like wasting","volume":"33","author":"Figueroa-Clarevega","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cvr\/cvt272","article-title":"Bedside to bench: a look at experimental research with a clinical trial checklist","volume":"101","author":"Sipido","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00075197-199901000-00005","article-title":"Of flux and flooding: the advantages and problems of different isotopic methods for quantifying protein turnover in vivo: I. Methods based on the dilution of a tracer","volume":"2","author":"Reeds","year":"1999","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JES.0b013e3182798a95","article-title":"Measuring protein synthesis with SUnSET: a valid alternative to traditional techniques?","volume":"41","author":"Goodman","year":"2013","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCO.0b013e328338b9a6","article-title":"MAFbx\/Atrogin-1 expression is a poor index of muscle proteolysis","volume":"13","author":"Attaix","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0300","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","article-title":"Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?","volume":"1830","author":"Fontes-Oliveira","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0305","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0310","doi-asserted-by":"crossref","first-page":"F280","DOI":"10.1152\/ajprenal.00113.2010","article-title":"Bioimpedance spectroscopy for the estimation of body fluid volumes in mice","volume":"299","author":"Chapman","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0083618","article-title":"Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle","volume":"9","author":"Johns","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0320","first-page":"2434","article-title":"Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure","volume":"35","author":"Corbett","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0325","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2147\/DDDT.S49584","article-title":"Animal models and therapeutic molecular targets of cancer: utility and limitations","volume":"8","author":"Cekanova","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0330","first-page":"484","article-title":"Orthotopic mouse model of colorectal cancer","author":"Tseng","year":"2007","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0335","first-page":"4090","article-title":"Amino acid, glucose, and lactic acid utilization in vivo by rat tumors","volume":"42","author":"Sauer","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0340","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1\u03b1 isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0345","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/17460440903300842","article-title":"Animal models of anorexia and cachexia","volume":"4","author":"DeBoer","year":"2009","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0350","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0355","doi-asserted-by":"crossref","first-page":"e73931","DOI":"10.1371\/journal.pone.0073931","article-title":"Enhanced cancer metastasis in mice deficient in vasohibin-1 gene","volume":"8","author":"Ito","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0360","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29620","article-title":"Tumor inoculation site affects the development of cancer cachexia and muscle wasting","author":"Matsuyama","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mex.2015.02.001","article-title":"Storage conditions and passages alter IL-6 secretion in C26 adenocarcinoma cell lines","volume":"2","author":"Norden","year":"2015","journal-title":"MethodsX"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0370","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01635581.2011.563032","article-title":"Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo","volume":"63","author":"Shadfar","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0375","doi-asserted-by":"crossref","first-page":"e87776","DOI":"10.1371\/journal.pone.0087776","article-title":"C26 cancer-induced muscle wasting is IKK\u03b2-dependent and NF-kappaB-independent","volume":"9","author":"Cornwell","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0380","article-title":"Cancer cachexia is associated with decreased responsiveness of immune cells to immunomodulatory cytokines","volume":"68","author":"Lesinski","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0385","first-page":"5","article-title":"Muscle wasting and impaired Myogenesis in tumor bearing mice are prevented by ERK inhibition","author":"Penna","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0390","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2013-1179","article-title":"Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice","volume":"154","author":"Garcia","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0395","article-title":"A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy","author":"Toledo","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0400","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00520-013-2081-3","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy","volume":"22","author":"Greig","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0405","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0410","doi-asserted-by":"crossref","first-page":"e113931","DOI":"10.1371\/journal.pone.0113931","article-title":"Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3","volume":"9","author":"Toledo","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0415","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Prado","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0420","article-title":"Chemotherapy-induced muscle wasting: association with NF-\u03baB and cancer cachexia","author":"Damrauer","year":"2008","journal-title":"Basic Appl. Myol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0425","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1139\/apnm-2013-0554","article-title":"Exercise training as treatment in cancer cachexia","volume":"39","author":"Lira","year":"2014","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0430","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0899-9007(99)00095-7","article-title":"Cachexia in experimental models","volume":"15","author":"Emery","year":"1999","journal-title":"Nutrition"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0435","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia-cachexia syndrome","volume":"19","author":"Bennani-Baiti","year":"2011","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0440","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1517\/17460441.2015.1041914","article-title":"Developing models for cachexia and their implications in drug discovery","volume":"10","author":"Konishi","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0445","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1517\/14712598.2010.503773","article-title":"Anti-cytokine strategies for the treatment of cancer-related anorexia and cachexia","volume":"10","author":"Penna","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0450","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1097\/MLG.0b013e3181453658","article-title":"Comparison of animal models for head and neck cancer cachexia","volume":"117","author":"Cannon","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0455","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/01635581.2013.776089","article-title":"Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers","volume":"65","author":"Yanagihara","year":"2013","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0460","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0465","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0470","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"10.1016\/j.semcdb.2015.09.002_bib0475","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/path.4142","article-title":"Activin-\u03b2(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice","volume":"229","author":"Gold","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0480","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0485","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0168-8278(03)00086-2","article-title":"Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model","volume":"38","author":"Dupuy","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.semcdb.2015.09.002_bib0490","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13539-014-0129-y","article-title":"Abstracts of the 7th Cachexia Conference, Kobe\/Osaka, Japan, December 9\u201311, 2013 (part 2)","volume":"5","author":"Anon.","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T14:55:50Z","timestamp":1537368950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952115001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":49,"alternative-id":["S1084952115001615"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.09.002","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}